brandon lewis

Trout Capital was formed in 2004 for the express purpose of establishing a legal entity under which its members could receive fees for services rendered in relationship to fundraising services. This was a logical evolution for Trout Group to take since it had assisted a considerable number of its clients in finding and securing capital through relationships with agents and investors already servicing the industry. The modification of the private placement regulations along with the ease of Shelf Registrations made it easier for small companies to coordinate modest capital formations relatively efficiently. The Trout Group's unique position in the marketplace provides the perfect vehicle for functioning as an intermediary in financial transactions. Investment bankers function as intermediaries in financial transactions as they are experienced in carrying out projects that, for most companies, take place very rarely, but are critically important.

Providing investment banking and advisory services to biotechnology, specialty pharmaceutical, medical device, and diagnostic companies. Extensive experience working on a wide variety of transactions including ADRs, PIPEs, registered directs, IPOs, follow-ons, private placements, licensing and M&A transactions.

Founder – Independent Film Production New York, New York Larrikin Films LLC is a film, media development and production company based in New York City. Founded in 2007, Larrikin is dedicated to bridging private equity to creative projects, with a niche focus on international co-ventures by providing strategic marketing strategies and financial analysis through various stages of development and production. As founder and lead executive, leverage extensive experience in international investor relations, brand marketing, client relationship, and business development in support of industry executives and economic development officials globally.

Interim Chief Business Officer – Stealth Mode Biopharmaceutical Company Stonington, Connecticut Gaila is a development stage biopharmaceutical company focusing on the discovery and development of new drugs to treat hormonal and reproductive system disorders.

The Trout Group was founded in 1995 to provide high-level investor relations services to the biotechnology industry. Our experience and knowledge of the industry allowed us to grow into a leading investor relations firm in the sector. Establishing a global reach, with clients, offices or contacts in all of the major global financial centers. As a key member of the founding team responsible for building the business from 3 to 55 retainer based clients and growing revenues by a similar multiple. During my tenure personnel grew from 3 to 35 full-time professionals and offices established in Boston, New York, San Francisco, and London. Since the firms’ inception, we have helped over 100 public and private companies across the globe and of all sizes and stages of development achieve their investor relations’ goals.